1. Home
  2. CNTX vs FMY Comparison

CNTX vs FMY Comparison

Compare CNTX & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

SELL

Current Price

$0.16

Market Cap

47.7M

Sector

Health Care

ML Signal

SELL

Logo First Trust Motgage Income Fund of Beneficial Interest

FMY

First Trust Motgage Income Fund of Beneficial Interest

SELL

Current Price

$10.98

Market Cap

47.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
CNTX
FMY
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
47.0M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
CNTX
FMY
Price
$0.16
$10.98
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $3.79
N/A
AVG Volume (30 Days)
★ 1.2M
4.6K
Earning Date
11-10-2026
01-01-0001
Dividend Yield
N/A
★ 6.98%
EPS Growth
★ 17.39
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$10.67
52 Week High
$3.62
$12.36

Technical Indicators

Market Signals
Indicator
CNTX
FMY
Relative Strength Index (RSI) 32.26 41.73
Support Level N/A $10.73
Resistance Level $0.22 $11.52
Average True Range (ATR) 0.02 0.20
MACD 0.00 -0.02
Stochastic Oscillator 12.13 7.41

Price Performance

Historical Comparison
CNTX
FMY

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.

Share on Social Networks: